BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2623239)

  • 1. [Pleuropulmonary tumors. Presentation of 2 cases with peculiar clinicopathologic traits].
    Esquius Soriguera J; Alejo Sánchez M; Padilla Navas I; Rodríguez Casquero C; León González C
    Rev Clin Esp; 1989 Oct; 185(6):303-5. PubMed ID: 2623239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma.
    Kobashi Y; Matsushima T; Irei T
    Respirology; 2005 Nov; 10(5):660-5. PubMed ID: 16268922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma.
    Ordóñez NG
    Am J Surg Pathol; 1989 Apr; 13(4):276-91. PubMed ID: 2648877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical comparison of diffuse malignant mesothelioma of the pleura and pseudomesotheliomatous carcinoma of the lung for each case].
    Yuasa H; Tomoyasu M
    Kyobu Geka; 1999 Sep; 52(10):836-9. PubMed ID: 10478545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pseudomesotheliomatous carcinoma of the lung].
    Maeda R; Isowa N; Kawasaki Y; Tokuyasu H; Itakura A; Miura H; Onuma H
    Kyobu Geka; 2007 Jul; 60(7):555-8. PubMed ID: 17642217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of membranous staining of mesothelioma.
    King JA; Tucker JA
    Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coalescent pleural malignant mesothelioma and adenocarcinoma of the lung, involving only minor asbestos exposure.
    Tsuzuki T; Ninomiya H; Natori Y; Ishikawa Y
    Pathol Int; 2008 Jul; 58(7):451-5. PubMed ID: 18577116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant mesothelioma of the pleura. Analysis of its immunohistochemical aspects].
    Chenard-Neu MP; Bellocq JP; Maier A; Batzenschlager A
    Ann Pathol; 1990; 10(1):20-7. PubMed ID: 2328062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomesotheliomatous adenocarcinoma: a reappraisal.
    Koss M; Travis W; Moran C; Hochholzer L
    Semin Diagn Pathol; 1992 May; 9(2):117-23. PubMed ID: 1609154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case reports of primary pulmonary adenocarcinoma with pleural spread: so-called pseudomesotheliomatous adenocarcinoma.
    Saito R; Kasajima A; Taniuchi S; Fujishima F; Ishida K; Nakamura Y; Yamanda S; Takahashi T; Hitomi H; Murakami K; Watanabe M; Sasano H
    Pathol Int; 2012 Oct; 62(10):709-15. PubMed ID: 23005599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucin-positive epithelial mesothelioma and pseudomesotheliomatous adenocarcinoma.
    Friedman HD; Litovsky SH; Abraham JL
    Arch Pathol Lab Med; 1993 Oct; 117(10):967. PubMed ID: 8215835
    [No Abstract]   [Full Text] [Related]  

  • 13. DNA ploidy analysis of pleural mesotheliomas: its usefulness for their distinction from lung adenocarcinomas.
    Esteban JM; Sheibani K
    Mod Pathol; 1992 Nov; 5(6):626-30. PubMed ID: 1369798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronous occurrence of pulmonary adenocarcinoma and pleural diffuse malignant mesothelioma.
    Imenpour H; Ivaldi GP; Brianti A; Pastorino G; Biggi S; Auriati L; Simonassi C
    Pathologica; 2013 Dec; 105(6):353-6. PubMed ID: 24730341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
    Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
    Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancies in the lung and pleura mimicking benign processes.
    Colby TV
    Semin Diagn Pathol; 1995 Feb; 12(1):30-44. PubMed ID: 7770673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of CEA, EMA, and BerEp4 and hyaluronan analysis specifically identifies 79% of all histologically verified mesotheliomas causing an effusion.
    Dejmek A; Hjerpe A
    Diagn Cytopathol; 2005 Mar; 32(3):160-6. PubMed ID: 15690331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistent atypical adenomatous hyperplasia, primary lung adenocarcinoma and pleural mesothelioma in an asbestos-exposed subject.
    Thomas DH; Attanoos RL; Gibbs AR
    Histopathology; 2004 Nov; 45(5):540-2. PubMed ID: 15500660
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of patterns of metastasis between malignant pleural mesotheliomas and pulmonary carcinomas].
    Scharmach M; Neumann V; Müller KM; Fischer M
    Pneumologie; 2006 May; 60(5):277-83. PubMed ID: 16703480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.
    Brown RW; Clark GM; Tandon AK; Allred DC
    Hum Pathol; 1993 Apr; 24(4):347-54. PubMed ID: 7684019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.